Elevation of cyclic AMP causes an imbalance between NF-κB and p53 in NALM-6 cells treated by doxorubicin

FEBS Letters

Volumn 584, Issue 15, 2010, Pages 3492-3498

  Safa, Majid ^a   Zand, Hamid ^b   Mousavizadeh, Kazem ^a   Kazemi, Ahmad ^a   Bakhshayesh, Masoumeh ^a   Hayat, Parisa ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CAMP; DNA damage; I B; NF B; P53

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOXORUBICIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA; DOXORUBICIN; ENZYME INHIBITORS; HUMANS; I-KAPPA B PROTEINS; INTRACELLULAR SPACE; NF-KAPPA B; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77955277457     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.07.009     Document Type: Article

References (29)

1. Yang C.R., Wilson-Van Patten C., Planchon S.M., Wuerzberger-Davis S.M., Davis T.W., Cuthill S., Miyamoto S., Boothman D.A. Coordinate modulation of Sp1, NF-kappa B, and p53 in confluent human malignant melanoma cells after ionizing radiation. FASEB 2000, 14:379.
2. Colman M.S., Afshari C.A., Barrett J.C. Regulation of p53 stability and activity in response to genotoxic stress. Mutat. Res. 2000, 462:179-188.
3. Luo J.L., Kamata H., Karin M. IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J. Clin. Invest. 2005, 115:2625-2632.
4. Kaltschmidt B., Kaltschmidt C., Hofmann T.G., Hehner S.P., Droge W., Schmitz M.L. The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. Eur. J. Biochem. 2000, 267:3828-3835.
5. Naderi E.H., Findley H.W., Ruud E., Blomhoff H.K., Naderi S. Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation. Blood 2009, 114:608-618.
6. Safa M., Kazemi A., Zand H., Azarkeivan A., Zaker F., Hayat P. Inhibitory role of cAMP on doxorubicin-induced apoptosis in pre-B ALL cells through dephosphorylation of p53 serine residues. Apoptosis 2009, 1:1.
7. Piret B., Schoonbroodt S., Piette J. The ATM protein is required for sustained activation of NF-kappaB following DNA damage. Oncogene 1999, 18:2261-2271.
8. Wu C.J., Conze D.B., Li T., Srinivasula S.M., Ashwell J.D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat. Cell Biol. 2006, 8:398-406.
9. Wuerzberger-Davis S.M., Nakamura Y., Seufzer B.J., Miyamoto S. NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage. Oncogene 2007, 26:641-651.
10. Huang T.T., Wuerzberger-Davis S.M., Wu Z.H., Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003, 115:565-576.
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
12. Boulakia C.A., Chen G., Ng F.W., Teodoro J.G., Branton P.E., Nicholson D.W., Poirier G.G., Shore G.C. Bcl-2 and adenovirus E1B 19kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene 1996, 12:529-535.
13. Richards J.P., Bachinger H.P., Goodman R.H., Brennan R.G. Analysis of the structural properties of cAMP-responsive element-binding protein (CREB) and phosphorylated CREB. J. Biol. Chem. 1996, 271:13716-13723.
14. Bender K., Gottlicher M., Whiteside S., Rahmsdorf H.J., Herrlich P. Sequential DNA damage-independent and -dependent activation of NF-[kappa]B by UV. EMBO J. 1998, 17:5170-5181.
15. Perkins N.D. NF-kappaB: tumor promoter or suppressor?. Trends Cell. Biol. 2004, 14:64-69.
16. Salvatore C., Camarda G., Maggi C.A., Goso C., Manzini S., Binaschi M. NF-kappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780. Int. J. Oncol. 2005, 27:799-806.
17. Brooks C.L., Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr. Opin. Cell. Biol. 2003, 15:164-171.
18. Braun T., Carvalho G., Fabre C., Grosjean J., Fenaux P., Kroemer G. Targeting NF-kappaB in hematologic malignancies. Cell Death Differ. 2006, 13:748-758.
19. Zhong H., May M.J., Jimi E., Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 2002, 9:625-636.
20. Ollivier V., Parry G.C., Cobb R.R., de Prost D., Mackman N. Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J. Biol. Chem. 1996, 271:20828-20835.
21. Tiwari S., Felekkis K., Moon E.Y., Flies A., Sherr D.H., Lerner A. Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis. Blood 2004, 103:2661-2667.
22. Ji Z., Mei F.C., Johnson B.H., Thompson E.B., Cheng X. Protein kinase A, not Epac, suppresses hedgehog activity and regulates glucocorticoid sensitivity in acute lymphoblastic leukemia cells. J. Biol. Chem. 2007, 282:37370-37377.
23. Rochais F., Vandecasteele G., Lefebvre F., Lugnier C., Lum H., Mazet J.L., Cooper D.M., Fischmeister R. Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels. J. Biol. Chem. 2004, 279:52095-52105.
24. Mailhes J.B., Hilliard C., Lowery M., London S.N. MG-132, an inhibitor of proteasomes and calpains, induced inhibition of oocyte maturation and aneuploidy in mouse oocytes. Cell Chromosome 2002, 1:2.
25. Kubbutat M.H., Vousden K.H. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol. Cell. Biol. 1997, 17:460-468.
26. Pianetti S., Arsura M., Romieu-Mourez R., Coffey R.J., Sonenshein G.E. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 2001, 20:1287-1299.
27. Gurova K.V., et al. Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors. Proc. Natl. Acad. Sci. USA 2005, 102:17448-17453.
28. Ikeda A., et al. P300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53. Biochem. Biophys. Res. Commun. 2000, 272:375-379.
29. Wang M.T., Honn K.V., Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev. 2007, 26:525-534.